The second class of drugs approved to treat the cognitive symptoms of neurocognitive disorder regulate the activity of the neurotransmitter glutamate.
Glutamate is a dominant excitatory neurotransmitter this is
launched with the aid of nerve cells inside the brain. It’s far liable for
sending signals among nerve cells, and beneath normal conditions it performs a
critical function in learning and memory.